DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: TREATMENTS
       *****************************************************
       #Post#: 3825--------------------------------------------------
       (ECTRIMS) Higher relapse rate w/rituximab vs ocrelizumab in MS R
       egistry data
       By: agate Date: November 2, 2022, 1:38 am
       ---------------------------------------------------------
       From MedPage Today (November 1, 2022)--"Higher relapse rate with
       rituximab vs ocrelizumab in MS Registry data":
  HTML https://www.medpagetoday.com/meetingcoverage/ectrims/101534
       *****************************************************